Aim: The present study was intended to establish the reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly (aged 80 years or more) Chinese men.
Introduction
With the aging of the population, osteoporosis has increasingly become a health challenge worldwide. Osteoporosis is a condition characterized by a decrease in bone mineral density (BMD), and loss of structural and biomechanical properties of the skeleton, leading to enhanced bone fragility and a consequent increase in fracture risk. 1 Osteoporosis not only results in impaired quality of life, loss of function and independence, and increased morbidity and mortality, 2 but also yields a heavy burden for the individual, as well as huge cost to the healthcare system. 3 Osteoporosis occurs primarily in postmenopausal women and older men. It was reported that after the age of 50 years, the prevalence of osteoporosis and incidence of osteoporotic fractures rose dramatically with age. 4 Based on BMD measurements in Caucasians, osteoporosis was present in 15% of those aged 50-59 years, but this figure increased quickly to 70% of those aged over 80 years. 5 Nguyen et al. found that compared with men aged 70-74 years, those aged older than 80 years had 28-fold as many vertebral fractures, ninefold as many hip fractures and nearly fivefold as many overall fractures. 6 According to the literature, the incidence rate of osteoporosis in very elderly (aged 80 years or older) men in mainland China was estimated to be as high as 40%.
have shown that men have increased morbidity and mortality associated with osteoporotic fractures compared with women. 8 As a consequence, prevention and treatment of osteoporosis in very elderly men constitutes an essential part of the campaign against osteoporosis.
Bone remodeling is a dynamic process of spatiotemporal coupling that involves bone resorption mediated by osteoclasts and bone formation induced by osteoblasts. In routine practice, osteoporosis is diagnosed and its treatment is assessed by measuring BMD. Unfortunately, BMD changes extremely slowly, an observable change often takes over several months, even years. 9 In contrast, as the indicator of bone loss or formation, bone turnover markers (BTM) alter much more rapidly. They can be used to assess the efficacy of osteoporosis treatment earlier than BMD measurements, determine the possible causes of secondary osteoporosis, 10 predict future fracture risk 11 and contribute to patients' adherence to osteoporosis treatment. 12 BTM include enzymes from bone cells and bone matrix of their degradation products. Among them, β-C-terminal telopeptide of type I collagen (β-CTX), procollagen type I N-terminal propeptide (P1NP) and osteocalcin (OC) are commonly used in the management of osteoporosis. β-CTX is a degradation product of type I collagen, and is released into the circulation during bone resorption, thereby being considered as an indicator for bone absorption. Conversely, P1NP is known as an index for osteogenesis, because it is cleaved from procollagen and released into the circulation during bone formation. Furthermore, as a bone-specific calcium-binding protein produced by osteoblasts, OC plays a role in the body's metabolic regulation and is pro-osteoblastic by nature. It was documented to be an independent predictor for osteoporotic fracture. 13 Development of the reference intervals for healthy subjects is the first step towards utilization of BTM in the management of osteoporosis. Despite some studies exploring the reference intervals of BTM for elderly men, the reference intervals of BTM for very elderly men had not been well established. 14, 15 With an attempt to develop the reference intervals of β-CTX, P1NP and OC for very elderly Chinese men, we investigated the serum levels of β-CTX, P1NP and OC in 1316 Chinese men aged 80 years or older, and identified 208 very elderly men without abnormal bone mass, chronic obstructive pulmonary disease (COPD) and/or type 2 diabetes mellitus (T2DM) as healthy participants. The present results also suggest β-CTX could be preferable among the three BTMs for the management of osteoporosis in very elderly Chinese men.
Methods

Study participants
From January 2013 to October 2015, a total of 1316 very elderly Chinese men who lived in east China were recruited from the Center for Diagnosis and Treatment of Osteoporosis in Zhejiang Provincial People's Hospital. The inclusion criteria were: (i) Chinese Han men aged 80 years or older; and (ii) being capable of receiving BMD measurement and BTM assay. The exclusion criteria were: (i) subjects had received anti-osteoporosis medications including bisphosphonates, calcitonins, denosumab, raloxifene, teriparatide and strontium ranelate; ii) taking glucocorticoids, anticonvulsants, androgen-stimulation or -deprivation therapy for more than 2 weeks or within the previous 12 months; (iii) serious renal disease defined as estimated glomerular filtration rate (Cockcroft-Gault method) less than 30 mL/min; (iv) a history of Paget's disease, hyperparathyroidism, rheumatoid arthritis, cancer and metabolic or inherited bone disease; and (v) had experienced bone fracture in the 6 months directly preceding the study.
The study was approved by the institutional review board of Zhejiang Provincial People's Hospital, and all participants gave their written informed consent.
Investigation of clinical characteristics
For all participants, clinical characteristics including age and medication history were recorded. The data on underlying diseases, such as hypertension, coronary heart disease, T2DM, COPD and chronic gastritis, were also collected based on medical history, and verified in accordance with the guidelines for specific diseases.
Measurements of BMD
BMD at the lumbar spine (posterior-anterior projection, L1-4), femoral neck and total hip were measured by using a dual-energy X-ray absorptiometry scanner (Lunar Prodigy, GE Healthcare, Madison, WI, USA), and expressed in g/cm 2 . Quality control was carried out using a spine phantom provided by the manufacturer before measurement every day. Measurement, quality control and data analysis were carried out by a skilled technician who was blind to patients' clinical data. The coefficients of variation of measurements were less than 2% at all sites. According to the World Health Organization, a T-score of -2.5 SD or less at any site was defined as osteoporosis, -2.5 < Tscore < -1.0 osteopenia and T-score ≥ -1.0 normal. Both osteoporosis and osteopenia were defined as abnormal bone mass.
Assays of BTM
After fasting overnight, venous blood samples were collected from all participants between 07.00 hours and 09.00 hours. Blood samples were placed at ambient temperature for 30 min for coagulation, followed by centrifugation at 2500 g for 10 min to separate serum, and then stored at -70°C for further analysis. Serum concentrations of β-CTX, P1NP and OC were measured with electrochemiluminescence immunoassay by using an automatic device (Roche cobas e 601 Automated Analyzer; Roche Diagnostics, Tokyo, Japan). The intraand interassay coefficients of variation were 2.0% and 4.2% for β-CTX, 0.8% and 4.0% for P1NP, and 0.5% and 1.4% for OC, respectively.
Statistical analysis
All statistical analyses were carried out with SPSS for Windows version 17.0 (SPSS, Chicago, IL, USA). Results were expressed as mean ± standard deviation (SD) or median (interquartile range) for quantitative variables, or numbers and percentages for qualitative variables. The one-sample Kolmogorov-Smirnov test was carried out to assess data distribution. As expected, the serum levels of BTM were not normally distributed, and the Mann-Whitney U-test was used for group comparisons. Linear correlations between different BTM were determined using Spearman's rank-order correlation coefficients, and partial correlations were carried out to explore the relationships between BMD and BTM with BMD being adjusted by age. Reference interval was defined as the distribution of values that encompass the central 95% range of all observations (percentile 2.5-97.5). All P-values were two-sided, and a P-value <0.05 was considered of statistical significance.
Results
Clinical characteristics of participants
The study included 1316 very elderly Chinese men. There were 1033 participants with hypertension, 214 (16.3%) with coronary heart disease, 373 (28.3%) with T2DM, 460 (35.0%) with COPD, 452 (34.3%) with chronic gastritis and 821 (62.4%) with abnormal bone mass (177 osteoporosis plus 644 osteopenia). The other clinical characteristics of the study population including age and serum concentrations of β-CTX, P1NP and OC are presented in Table 1 .
Association of underlying diseases with BTM in 1316 very elderly Chinese men
It was found that participants with T2DM had lower serum levels of β-CTX, P1NP and OC than those without (P < 0.001), and participants with COPD had higher serum levels of β-CTX and OC than those without (P < 0.01). In addition, the serum concentrations of β-CTX, P1NP and OC were increased in participants with abnormal bone mass compared with those with normal bone mass (P < 0.01), as shown in Table 2 . As a result, the participants who had T2DM, COPD or abnormal bone mass were excluded. The remaining 208 very elderly men were finally identified as the healthy participants under current study settings, and their serum levels of β-CTX, P1NP and OC were used to deduce the reference intervals.
Reference intervals of β-CTX, P1NP and OC for very elderly Chinese men . The reference intervals of the BTM were obtained through defining the central 95% range of all observations (percentile 2.5-97.5), which were 0.13-0.63 ng/mL for β-CTX, 18-94 ng/mL for P1NP and 9-28 ng/mL for OC, respectively. The reference intervals of β-CTX, P1NP and OC for different age groups were also obtained, which are detailed in Table 3 .
Correlations among different BTM or between BMD and BTM in 208 healthy participants
It was shown that three BTM were moderately correlated to each other (P < 0.001) in 208 healthy participants, as shown in Figure 1 . We also documented that all these BTM were negatively associated with the age-adjusted BMD at the lumbar spine, femoral neck and total hip (P < 0.01), as shown in Table 4 .
Discussion
The potential of BTM as an additional tool to assess antiosteoporosis efficacy, predict fracture risk and probe the causes of osteoporosis is promising for healthcare professionals, as it could improve outcomes and decrease costs. In very elderly men, however, using these BTM effectively for the management of osteoporosis is still far away. A major reason is that very elderly men are subject to a multitude of chronic diseases that might impact on the serum levels of BTM, making it difficult to identify healthy subjects in terms of bone metabolism. We found in a present 16 (12) (13) (14) (15) (16) (17) (18) (19) study that out of 1316 very elderly Chinese men, there were 1033 with hypertension, 214 with coronary heart disease, 373 with T2DM, 461 with COPD, 452 with chronic gastritis and 821 with abnormal bone mass. All these conditions had been taken into consideration in the study for their potential influence on the serum concentration of BTM, in addition to some wellestablished factors, such as anti-osteoporotic agents, glucocorticoids, anticonvulsants, severe renal dysfunction and so on. With regard to the relationship between diabetes mellitus and osteoporosis, a recent perception is that patients with type 1 diabetes mellitus are susceptible to osteoporosis, 16 whereas the association of T2DM with osteoporosis is controversial. 17, 18 Similar to the results by two research teams, 19, 20 we found among 1316 veryelderly Chinese men the serum levels of three BTM for participants with T2DM were significantly lower than those for participants without T2DM, which might be relative to some clinical features frequently observed in elderly men, such as diet, weight loss and elevated insulin levels. 21, 22 Osteoporosis is one of the common extrapulmonary effects on elderly patients with COPD. It was shown that very elderly Chinese men with COPD had lifted serum levels of β-CTX and OC compared with those without COPD, a finding similar to that by Wang et al. 23 There were several factors potentially responsible for the Includes osteoporosis (n = 177) and osteopenia (n = 644). β-CTX, β-C-terminal telopeptide of type I collagen; COPD chronic obstructive pulmonary disease; OC, osteocalcin; P1NP, procollagen type I N-terminal propeptide; T2DM, type 2 diabetes mellitus. enhanced BTM levels, such as continuous hypoxia, hypercarbia, weakened sports ability and frequent glucocorticoids medications. 24, 25 In line with the results from some studies in recent years, 26, 27 it was shown that very elderly Chinese men who had abnormal bone mass manifested higher BTM levels than those who had normal bone mass. Elevated BTM levels are usually indicative of overactive osteoclast function, resulting in enhanced bone resorption compared with bone formation, leading to accelerated bone loss and decreased bone mass.
As our findings that T2DM, COPD and abnormal bone mass were correlated to the serum levels of BTM, the very elderly Chinese men with T2DM, COPD and abnormal bone mass were finally excluded from the healthy participants. We then established the reference intervals of three BTM for very elderly Chinese men from the observations of the remaining 208 healthy participants, they were 0.13-0.63 ng/mL for β-CTX, 18-94 ng/mL for P1NP and 9-28 ng/mL for OC, respectively. The Chinese Bone Turnover Marker Study had also suggested the reference intervals of β-CTX and P1NP for men aged older than 80 years from 34 healthy participants, but its graphically illustrated values cannot be compared with ours directly.
14 In addition, Olmos et al. recommended the reference intervals of two BTM for men aged older than 80 years, they were 0.238-0.475 ng/mL for β-CTX and 29.3-48.9 ng/mL for P1NP, respectively. It should be noted that these reference intervals were obtained by calculating the geometric mean ± 2SD of the observations from 41 healthy Spanish participants, and were obviously different from the values we recommended. 15 More importantly, the reference intervals recommended by both groups were established on the basis of taking no account of the influence of underlying diseases on BTM. As a consequence, the inconsistency of our recommendations with others might be explained at least in part by the differences in ethnicity, number of healthy participants, inclusion and exclusion criteria, and definition of reference interval.
β-CTX, P1NP and OC are three BTM commonly used in clinical practice. It was shown in the present study that they were moderately correlated to each other, and all inversely correlated to the BMD at the lumbar spine, femoral neck and total hip. These findings signify that an increase in any of the BTM has a similar clinical implication, namely, being indicative of accelerated bone resorption. In terms of the correlation coefficient, however, β-CTX presented the highest correlation with the BMD of all three sites. We previously found among three BTM that only β-CTX was the independent factor negatively related to the BMD at the femoral neck, denoting its relatively high values for the management of osteoporosis in very elderly men. 28 In addition, Zhao et al. documented among β-CTX, P1NP and 25-hydroxyvitamin D, only β-CTX was significantly higher in postmenopausal women with sustained fracture or vertebral fracture than in the control groups. 29 Ivaska et al. showed among seven BTM, only β-CTX was found to be associated with fracture risk (hazard ratio per SD, 1.13) and vertebral fracture risk (hazard ratio per SD, 1.32) in elderly women. 30 Furthermore, β-CTX is one of the two BTM recommended by the International Osteoporosis Foundation and the International Federation of Clinical Chemistry and Laboratory Medicine Working Group. Taking all these into consideration, we suggest that β-CTX could be the preferable among the three BTM for the management of osteoporosis in very elderly men.
The limitations of the present study should be addressed. First, the relative small number of study participants limited the applicability of the reference intervals established in the study. Second, the participants surveyed were not well representative of the very elderly Chinese men despite the fact that there were no significant differences found in the β-CTX and PINP concentrations among different cities in China.
14 Further large-scale studies are warranted that take into consideration as many influential factors as possible.
To draw a conclusion, we have established the reference intervals of β-CTX, P1NP and OC for very elderly Chinese men from 208 healthy participants without T2DM, COPD and/or abnormal bone mass. Our recommendations might help to interpret bone turnover for the research and management of osteoporosis in very elderly Chinese men.
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